| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/31/2008 | CA2687557A1 Polyfunctional fullerene c60 amino acid derivatives |
| 12/30/2008 | US7470782 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 12/30/2008 | US7470776 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof |
| 12/30/2008 | US7470771 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/30/2008 | US7470721 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| 12/30/2008 | US7470675 Methods for treating cancer using interferon-ω-expressing polynucleotides |
| 12/30/2008 | US7470674 Dinucleotides modified by 2'-deoxy-7-deazaguanosine, arabinoguanosine and a glycerol linker;flexibility in the nature of immune response produced; overcoming of species specificities; vaccines; anticarcinogenic agents; autoimmune disorders; asthma;antiallergens ;bactericides; viricides; parasiticides |
| 12/30/2008 | US7470673 Using vector comprising nucleotide sequences coding atonal-associated polypetides as therapeutic tool in treating hearing impairment and inflammatory bone disorders; antiarthritic agents |
| 12/30/2008 | US7470670 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 12/30/2008 | US7470669 modulates an activity of the Lipolysis Stimulated Receptor, mechanisms of leptin elimination; for the treatment of obesity and obesity-related diseases and disorders; antilipemic agents |
| 12/30/2008 | US7470668 treating osteoporosis to increase osteogenesis in mammal; biodrug polypeptide for treating bone disorders; osteocrin, a bone secreted protein with prohormone like characteristics |
| 12/30/2008 | US7470667 Methods of treating cancer using a modified endostatin protein |
| 12/30/2008 | US7470666 injecting an aqueous solution containing dissolved freeze-dried ulinastatin powder; glycoprotein isolated from human urine, and also called human urine trypsin enzyme inhibitor |
| 12/30/2008 | US7470665 Antiproliferatory agents; antitumor agents; mixture of fibroblast growth factor and cytolysis agent |
| 12/30/2008 | US7470664 HCV NS3 protease inhibitors |
| 12/30/2008 | US7470663 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 12/30/2008 | US7470662 Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof |
| 12/30/2008 | US7470661 Delivery of superoxide dismutase to neuronal cells |
| 12/30/2008 | US7470660 reducing, prevention, reverse cholesterol transportation; supplying apolipoprotein |
| 12/30/2008 | US7470659 Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE) and Bruch's membrane (BM) |
| 12/30/2008 | US7470658 Methods for inhibiting tumor metastasis, and peptides useful therefor |
| 12/30/2008 | US7470523 Recombinant protein production in a human cell |
| 12/30/2008 | US7470510 Methods for diagnosing cancer and determining a susceptibility for developing cancer |
| 12/30/2008 | US7470436 Water-soluble composition containing coenzyme Q10 |
| 12/30/2008 | US7470431 Administering a therapeutic amount of a botulinum toxin into the prostate gland of a patient with prostate cancer, thereby alleviating a symptom of prostate cancer or its treatment |
| 12/30/2008 | US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization |
| 12/30/2008 | US7470428 Compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions and methods useful for promoting or inhibiting antigen-presenting cell (APC) activation. The invention is |
| 12/30/2008 | US7470422 Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
| 12/30/2008 | CA2501601C Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x using small unilamellar vesicles |
| 12/30/2008 | CA2391293C .beta.2-adrenergic receptor agonists |
| 12/30/2008 | CA2368767C Protease resistant flint analogs |
| 12/30/2008 | CA2355269C Materials and methods for making improved micelle compositions |
| 12/30/2008 | CA2263816C Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
| 12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
| 12/30/2008 | CA2223720C Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 12/30/2008 | CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 12/30/2008 | CA2162924C New peptide antagonists at glutamate and nmda receptors |
| 12/30/2008 | CA2143045C Lactic-acid-containing cyclic depsipeptides having 18 ring atoms as endoparasiticidal agents, and process for their preparation |
| 12/30/2008 | CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules |
| 12/25/2008 | US20080319551 Thioester-ester-amide copolymers |
| 12/25/2008 | US20080319185 Efficient Method To Synthesize Benzyl Group-Protected Alpha-Pentagalloylglucose (Alpha-Pgg) And Its Analogues |
| 12/25/2008 | US20080319183 Branched Polymeric Sugars and Nucleotides Thereof |
| 12/25/2008 | US20080319178 Chimera humanized vascular endothelial growth factor |
| 12/25/2008 | US20080319174 Chimera humanized vascular endothelial growth factor |
| 12/25/2008 | US20080319173 Blood group antigen fusion polypeptides and methods of use thereof |
| 12/25/2008 | US20080319167 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 12/25/2008 | US20080319165 Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide |
| 12/25/2008 | US20080318872 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 12/25/2008 | US20080318871 Treatment of neurological disorders |
| 12/25/2008 | US20080318870 Synthetic bile acid compositions and methods |
| 12/25/2008 | US20080318869 Method to Promote Wound Healing |
| 12/25/2008 | US20080318868 Use of Mycobacterial Mannosylated Lipoglycans Peptide Mimotopes For Treating Inflammation |
| 12/25/2008 | US20080318867 Virulent Phages to Control Listeria Monocytogenes in Foodstuffs and in Food Processing Plants |
| 12/25/2008 | US20080318866 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
| 12/25/2008 | US20080318865 Stabilized Pharmaceutical Peptide Compositions |
| 12/25/2008 | US20080318864 Methods and compositions regarding polychalcogenide compositions |
| 12/25/2008 | US20080318863 Ischemia therapeutic agent |
| 12/25/2008 | US20080318862 Crosslinkable polymeric materials and their applications |
| 12/25/2008 | US20080318861 Mucosal Delivery of Stabilized Formulations of Exendin |
| 12/25/2008 | US20080318860 High Activity Growth Factor Mutants |
| 12/25/2008 | US20080318859 Methods for Tissue Engineering |
| 12/25/2008 | US20080318858 comprises a modified amino acid sequence comprising one or more amino acid substitutions to an amino acid sequence; substitutions are selected from the group consisting of H98Y, E102K, E108K, E120K; use as complement inhibitor |
| 12/25/2008 | US20080318857 Compositions and Methods for the Intracellular Disruption of Vegf and Vegfr-2 By Intraceptors |
| 12/25/2008 | US20080318856 administering a monomer protein comprising an amino acid sequence belonging to the TGF- beta super family, wherein alanine at position 83 is replaced with a serine, threonine or valine; protein induces differentiation of osteoblasts measured by promoting alkaline phosphatase activity to a patient |
| 12/25/2008 | US20080318855 Dna encoding for recombinant polypeptide emutants of human stromal cell-derived factor 1 |
| 12/25/2008 | US20080318854 Method for regulating neurite growth |
| 12/25/2008 | US20080318853 Diagnostic and Therapeutic Use of a Novel Growth Factor, Neublasmin |
| 12/25/2008 | US20080318852 Epitopes Related to Coeliac Disease |
| 12/25/2008 | US20080318851 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 12/25/2008 | US20080318850 Glycopegylated Factor Ix |
| 12/25/2008 | US20080318849 Kahalalide F and Related Compounds |
| 12/25/2008 | US20080318848 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; anticarcinogenic agent; refractory cancer that does not respond favorably to other treatments; peptides isolated mollusc, Elysia Elysia rufescens and its diet, a green algae |
| 12/25/2008 | US20080318847 Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction |
| 12/25/2008 | US20080318846 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 12/25/2008 | US20080318845 Selective Vpac2 Receptor Peptide Agonists |
| 12/25/2008 | US20080318844 Composition and method for the treatment of diseases affected by histone deacetylase inhibitors |
| 12/25/2008 | US20080318843 Device and Method for the Delivery of Drugs for the Treatment of Posterior Segment Disease |
| 12/25/2008 | US20080318842 Cyclic Isodityrosine Derivatives |
| 12/25/2008 | US20080318841 Method For Preparing a Factor H Concentrate and the Use Thereof in the Form of a Drug |
| 12/25/2008 | US20080318840 Compositions of Alpha-Fetoprotein and Inducers of Apoptosis for the Treatment of Cancer |
| 12/25/2008 | US20080318839 Ligand activated transcriptional regulator proteins |
| 12/25/2008 | US20080318838 Peptides |
| 12/25/2008 | US20080318837 Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide |
| 12/25/2008 | US20080318836 sCD Fingerprints |
| 12/25/2008 | US20080318835 Novel Integrin Ligand ITGL-TSP |
| 12/25/2008 | US20080318803 Biomarkers for Monitoring Impdh Pathway Inhibition |
| 12/25/2008 | US20080318320 Targeting vector to the urokinase plasminogen activator receptor |
| 12/25/2008 | US20080318312 Pancreatic islet transcription factor and uses thereof |
| 12/25/2008 | US20080318276 Human Coagulation Factor VII Variants |
| 12/25/2008 | US20080318275 Hepatitis C virus asialoglycoproteins |
| 12/25/2008 | US20080318254 PSCA antibodies and hybridomas producing them |
| 12/25/2008 | US20080318253 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 12/25/2008 | US20080317886 Compositions for Preventing and Reducing Delayed Onset Muscle Soreness |
| 12/25/2008 | US20080317883 Methods for treating depression |
| 12/25/2008 | US20080317865 Quench liquids and washing systems for production of microparticles |
| 12/25/2008 | US20080317863 Pharmaceutical Compositions Useful in the Transmucosal Administration of Drugs |
| 12/25/2008 | US20080317861 Polymeric Materials and Methods |
| 12/25/2008 | US20080317860 Use of a Polysaccharide Which is Excreted by the Vibrio Diabolicus Species For the Engineering of Non-Mineralized Connective Tissue |
| 12/25/2008 | US20080317857 V-Atpase Inhibitors of Use in the Treatment of Septic Shock |
| 12/25/2008 | US20080317840 Compositions and methods for polymer-caged liposomes |